2024 Q3 Form 10-Q Financial Statement

#000121390024111270 Filed on December 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $470.4K
YoY Change -29.21%
Operating Profit -$1.285M -$470.4K
YoY Change 173.24% -29.21%
Interest Expense $2.596M
YoY Change 103.62%
% of Operating Profit
Other Income/Expense, Net -$243.0K
YoY Change 258.78%
Pretax Income $1.883M
YoY Change 246.86%
Income Tax
% Of Pretax Income
Net Earnings -$1.120M $1.883M
YoY Change -159.5% 246.86%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $259.0K
YoY Change -74.2%
Cash & Equivalents $115.0K $259.0K
Short-Term Investments
Other Short-Term Assets $43.38K
YoY Change -85.2%
Inventory
Prepaid Expenses $71.74K
Receivables
Other Receivables
Total Short-Term Assets $186.8K $302.4K
YoY Change -38.23% -76.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $155.3M
YoY Change -45.36%
Other Assets
YoY Change
Total Long-Term Assets $25.38M $155.3M
YoY Change -83.65% -45.36%
TOTAL ASSETS
Total Short-Term Assets $186.8K $302.4K
Total Long-Term Assets $25.38M $155.3M
Total Assets $25.57M $155.6M
YoY Change -83.57% -45.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $269.6K $173.0K
YoY Change 55.87% 665.36%
Accrued Expenses $1.102M
YoY Change 68.21%
Deferred Revenue
YoY Change
Short-Term Debt $154.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.509M $1.429M
YoY Change 75.6% 104.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $10.61M
YoY Change -5.38%
Total Long-Term Liabilities $10.61M
YoY Change -5.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.509M $1.429M
Total Long-Term Liabilities $10.61M
Total Liabilities $3.474M $12.04M
YoY Change -71.15% 1.08%
SHAREHOLDERS EQUITY
Retained Earnings -$3.288M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.287M $143.5M
YoY Change
Total Liabilities & Shareholders Equity $25.57M $155.6M
YoY Change -83.57% -45.5%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.120M $1.883M
YoY Change -159.5% 246.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$322.9K
YoY Change -16.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $140.4M
YoY Change
Cash From Investing Activities $140.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -140.1M
YoY Change
NET CHANGE
Cash From Operating Activities -322.9K
Cash From Investing Activities 140.4M
Cash From Financing Activities -140.1M
Net Change In Cash -47.86K
YoY Change -87.69%
FREE CASH FLOW
Cash From Operating Activities -$322.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
usd
CY2024Q3 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40677
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1581691
dei Entity Address Address Line1
EntityAddressAddressLine1
2021 Fillmore St., #2089
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94115
dei City Area Code
CityAreaCode
+1 (929)
dei Local Phone Number
LocalPhoneNumber
529-7129
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115044 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
71741 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25885 usd
CY2023Q4 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
225000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
186785 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
250885 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
25381830 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
157330245 usd
CY2024Q3 us-gaap Assets
Assets
25568615 usd
CY2023Q4 us-gaap Assets
Assets
157581130 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
269619 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1083498 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
805 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2509011 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
805 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
964734 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
723550 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3473745 usd
CY2023Q4 us-gaap Liabilities
Liabilities
724355 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
25381830 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
157555245 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3287753 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-699263 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3286960 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-698470 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25568615 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
157581130 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1285296 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
470399 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2281181 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1275093 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1285296 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-470399 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2281181 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1275093 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
652 usd
CY2024Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
285500 usd
CY2023Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2596438 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
1660800 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
9090382 usd
aptm Gain Related To Potential Business Combination
GainRelatedToPotentialBusinessCombination
374975 usd
CY2023Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1859 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1859 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
120592 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241184 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1120388 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1883025 usd
us-gaap Net Income Loss
NetIncomeLoss
-861565 usd
us-gaap Net Income Loss
NetIncomeLoss
7947874 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-698470 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1316981 usd
CY2024Q1 aptm Adjustments To Additional Paid In Capital Deemed Contribution For Extension Deposit From The Sponsor
AdjustmentsToAdditionalPaidInCapitalDeemedContributionForExtensionDepositFromTheSponsor
112500 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16346 usd
CY2024Q1 aptm Reversal Of Deemed Contribution For Extension Deposit From The Sponsor
ReversalOfDeemedContributionForExtensionDepositFromTheSponsor
112500 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-148236 usd
CY2024Q1 aptm Adjustments To Additional Paid In Capital Contribution From The Sponsor Of Shares To Be Issued Under Nonredemption Agreements
AdjustmentsToAdditionalPaidInCapitalContributionFromTheSponsorOfSharesToBeIssuedUnderNonredemptionAgreements
367610 usd
CY2024Q1 aptm Adjustment To Additional Paid In Capital Finance Cost Of Shares To Be Issued Under Nonredemption Agreements
AdjustmentToAdditionalPaidInCapitalFinanceCostOfSharesToBeIssuedUnderNonredemptionAgreements
367610 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2147341 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
283319 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
70170 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
407059 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1953431 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
285500 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
72359 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1120388 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3286960 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10717615 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3040790 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2120863 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11637542 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3453154 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3943986 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-11146710 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
572659 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3046438 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1883025 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-11737464 usd
us-gaap Net Income Loss
NetIncomeLoss
-861565 usd
us-gaap Net Income Loss
NetIncomeLoss
7947874 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1660800 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
9090382 usd
us-gaap Share Based Compensation
ShareBasedCompensation
158875 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241184 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
aptm Change In Fair Value Of Convertible Promissory Note Related Party
ChangeInFairValueOfConvertiblePromissoryNoteRelatedParty
1859 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
45856 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-150563 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
269619 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
103674 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
26027 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
15065 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1082693 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-167696 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-789823 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-742860 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
450000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
450000 usd
aptm Cash Transferred From Trust Account To Pay Redeeming Shareholders
CashTransferredFromTrustAccountToPayRedeemingShareholders
134059215 usd
aptm Cash Transferred From Trust Account To Pay Redeeming Shareholders
CashTransferredFromTrustAccountToPayRedeemingShareholders
140838808 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
133609215 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
140388808 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6000 usd
aptm Proceeds For Extension Payments From The Old Sponsor
ProceedsForExtensionPaymentsFromTheOldSponsor
225000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1129867 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
725000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
134059215 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
140838808 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-132704348 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-140113808 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
115044 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-467860 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726869 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115044 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259009 usd
aptm Reclassification Of Sponsor Extension Payment To Promissory Note Related Party
ReclassificationOfSponsorExtensionPaymentToPromissoryNoteRelatedParty
112500 usd
aptm Reclassification Of Sponsor Extension Payment To Promissory Note Related Party
ReclassificationOfSponsorExtensionPaymentToPromissoryNoteRelatedParty
572659 usd
aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
1885800 usd
aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
9540382 usd
CY2023Q4 aptm Purchased Founder Shares Units
PurchasedFounderSharesUnits
3902648 shares
CY2023Q4 us-gaap Sponsor Fees
SponsorFees
112500 usd
CY2024Q1 us-gaap Sponsor Fees
SponsorFees
112500 usd
CY2024Q3 aptm Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001 usd
aptm Percentage Of Restricted From Redeeming Shares
PercentageOfRestrictedFromRedeemingShares
1 pure
us-gaap Interest Expense Other
InterestExpenseOther
100000 usd
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
153169659 usd
CY2024Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
24629032 usd
CY2024Q3 aptm Monthly Payment Amount For Extension
MonthlyPaymentAmountForExtension
225000 usd
aptm Public Share Remains Outstanding
PublicShareRemainsOutstanding
0.03
CY2024Q1 us-gaap Deposits
Deposits
225000 usd
CY2023Q3 aptm Percentage Of Equity Holders
PercentageOfEquityHolders
1 pure
CY2024Q3 aptm Consecutive Business Days
ConsecutiveBusinessDays
P32D
CY2024Q3 us-gaap Trading Securities Debt
TradingSecuritiesDebt
35000000 usd
CY2024Q3 us-gaap Cash
Cash
115044 usd
CY2024Q3 aptm Working Capital Deficit
WorkingCapitalDeficit
2322226 usd
CY2024Q1 aptm Working Capital
WorkingCapital
250000 usd
CY2024Q1 aptm Sponsor Discretion Amount
SponsorDiscretionAmount
250000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. The initial valuation of the Public Warrants (as defined in Note 3) and Class A ordinary shares subject to redemption, the initial and the quarterly valuation of the Private Placement Warrants (as defined in Note 4), and the valuations for the convertible Note (as defined in Note 5) required management to exercise significant judgement in its estimates.</span></p>
CY2024Q3 us-gaap Cash
Cash
115044 usd
CY2023Q4 us-gaap Cash
Cash
0 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
25381830 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
157330245 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
165000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
495000 usd
CY2024Q1 aptm Working Capital
WorkingCapital
250000 usd
CY2024Q1 aptm Sponsor Discretion Amount
SponsorDiscretionAmount
250000 usd
CY2024Q3 aptm Sponsor Payments
SponsorPayments
243867 usd
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
331180 shares
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
331180 shares
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
331180 shares
CY2024Q1 aptm Non Redemption Agreement Amount
NonRedemptionAgreementAmount
367610 usd
CY2024Q1 aptm Non Redemption Agreement Amount
NonRedemptionAgreementAmount
367610 usd
CY2024Q1 aptm Non Redemption Agreement Amount
NonRedemptionAgreementAmount
367610 usd
CY2024Q1 aptm Percentage Of Fair Value Determined Discount
PercentageOfFairValueDeterminedDiscount
0.1095 pure
CY2024Q1 aptm Percentage Of Fair Value Determined Discount
PercentageOfFairValueDeterminedDiscount
0.1095 pure
CY2024Q1 aptm Percentage Of Fair Value Determined Discount
PercentageOfFairValueDeterminedDiscount
0.1095 pure
CY2024Q1 aptm Percentage Of Redemption Rights Discount
PercentageOfRedemptionRightsDiscount
0.05 pure
CY2024Q1 aptm Percentage Of Redemption Rights Discount
PercentageOfRedemptionRightsDiscount
0.05 pure
CY2024Q1 aptm Percentage Of Redemption Rights Discount
PercentageOfRedemptionRightsDiscount
0.05 pure
CY2024Q1 aptm Founder Shares Valuation Date Per Share
FounderSharesValuationDatePerShare
10.71
CY2024Q1 aptm Founder Shares Valuation Date Per Share
FounderSharesValuationDatePerShare
10.71
CY2024Q1 aptm Founder Shares Valuation Date Per Share
FounderSharesValuationDatePerShare
10.71
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
165000 shares
CY2024Q1 aptm Trading Price
TradingPrice
10.5
CY2024Q1 aptm Percentage Of Estimated Probability Of Completing Business Combination
PercentageOfEstimatedProbabilityOfCompletingBusinessCombination
0.089 pure
CY2024Q1 aptm Percentage Of Redemption Ability Of Founder Shares Discount
PercentageOfRedemptionAbilityOfFounderSharesDiscount
0.95 pure
CY2024Q1 aptm Estimated Fair Value Of Founder Warrants
EstimatedFairValueOfFounderWarrants
17500 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
72359 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
158875 usd
CY2023Q4 aptm Deferred Underwriting Commissions
DeferredUnderwritingCommissions
336175 usd
CY2024Q3 us-gaap Payments For Fees
PaymentsForFees
200000 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
aptm Newly Issued Price
NewlyIssuedPrice
10
aptm Redemption Trigger Price
RedemptionTriggerPrice
18
aptm Redemption Warrants Price
RedemptionWarrantsPrice
10
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
120592 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241184 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
dei Entity Registrant Name
EntityRegistrantName
Plum Acquisition Corp. III
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2024Q3 aptm Gain Related To Potential Business Combination
GainRelatedToPotentialBusinessCombination
usd
CY2023Q3 aptm Gain Related To Potential Business Combination
GainRelatedToPotentialBusinessCombination
usd
aptm Gain Related To Potential Business Combination
GainRelatedToPotentialBusinessCombination
usd
CY2024Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
aptm Change In Fair Value Of Convertible Promissory Note Related Party
ChangeInFairValueOfConvertiblePromissoryNoteRelatedParty
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
aptm Proceeds For Extension Payments From The Old Sponsor
ProceedsForExtensionPaymentsFromTheOldSponsor
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001845550

Files In Submission

Name View Source Status
aptm-20240930_pre.xml Edgar Link unprocessable
aptm-20240930_cal.xml Edgar Link unprocessable
0001213900-24-111270-index-headers.html Edgar Link pending
0001213900-24-111270-index.html Edgar Link pending
0001213900-24-111270.txt Edgar Link pending
0001213900-24-111270-xbrl.zip Edgar Link pending
aptm-20240930.xsd Edgar Link pending
ea0223853-10q_plumacq3.htm Edgar Link pending
ea022385301ex31-1_plumacq3.htm Edgar Link pending
ea022385301ex31-2_plumacq3.htm Edgar Link pending
ea022385301ex32-1_plumacq3.htm Edgar Link pending
ea022385301ex32-2_plumacq3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
aptm-20240930_def.xml Edgar Link unprocessable
aptm-20240930_lab.xml Edgar Link unprocessable
ea0223853-10q_plumacq3_htm.xml Edgar Link completed
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable